Dated disclosed rounds · latest 2022-03-01
Series B
Paragraf
Graphene-based semiconductors
VerifiedSeries BSomersham, Cambridgeshire
- Companies House
- 09889431
- GLEIF LEI
- 8945003MEQK1UBEM4R75
- Latest evidence
- 2022-03-01
- Evidence snapshot
- 2026-08-25
Exact award notices · latest No exact award match
2026-08-25T03:36:11.945Z
Jun 2026
Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.
Evidence timeline
7 dated observations
Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.
RegistryRecord observation Status observed: Active
Snapshot evidence only; this row does not claim the status changed on this date.
IdentifierReference metadata LEI record updated
8945003MEQK1UBEM4R75 · registration ISSUED
FundingSource fact Series C
$55M · 11 named investors
IdentifierReference metadata LEI first registered
8945003MEQK1UBEM4R75
FundingSource fact Series B
$60m · 7 named investors
FundingSource fact Series A
£12.8M · 5 named investors
RegistryRegistry fact Company incorporated
PARAGRAF LIMITED · company 09889431
Latest disclosed round
Series B
- Date
- 2022-03-01
- Amount
- USD 60m
- Sector
- Deeptech / hardware
- Companies House
- 09889431
- ONS region
- East
Evidence status
Directory ready
- Identity
- Verified
- Match
- High — exact company number and aligned registered name
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
7 linked investors
Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.
New Science VenturesleadAmadeus Capital PartnersparticipantBritish Patient CapitalparticipantIn-Q-TelparticipantIQ CapitalparticipantMolten VenturesparticipantParkwalkparticipant
| Investor | Role | Date | Source | Match / state |
|---|---|---|---|---|
| New Science Ventures | lead | 2022-03-01 | Paragraf ↗ · Moltenventures ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Amadeus Capital Partners | participant | 2022-03-01 | Paragraf ↗ · Moltenventures ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| British Patient Capital | participant | 2022-03-01 | Paragraf ↗ · Moltenventures ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| In-Q-Tel | participant | 2022-03-01 | Paragraf ↗ · Moltenventures ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| IQ Capital | participant | 2022-03-01 | Paragraf ↗ · Moltenventures ↗ · Vc ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Molten Ventures | participant | 2022-03-01 | Paragraf ↗ · Moltenventures ↗ · Moltenventures ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Parkwalk | participant | 2022-03-01 | Paragraf ↗ · Moltenventures ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
Funding record
3 disclosed rounds
Open a dated round to move directly between the company, named investors and source publication.
| Date | Stage | Amount | Investors | Named sources |
|---|---|---|---|---|
| 2025-08-25 | Series C | $55M | Amadeus Capital Partners · British Patient Capital · Cambridge Enterprise · IQ Capital · Molten Ventures · New Science Ventures · 4 additional source-listed names · + 1 more linked | Paragraf ↗ · Graphene Info ↗ |
| 2022-03-01 | Series B | $60m | New Science Ventures · Parkwalk · Amadeus Capital Partners · IQ Capital · Molten Ventures · British Patient Capital · + 1 more linked | Paragraf ↗ · Moltenventures ↗ |
| 2019-07-15 | Series A | £12.8M | Parkwalk · Amadeus Capital Partners · Cambridge Enterprise · 2 additional source-listed names | Paragraf ↗ · Amadeuscapital ↗ |
Companies House status and filing snapshot
PARAGRAF LIMITED
Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.
Registered record
- Status
- Active
- Company type
- Private Limited Company
- Country of origin
- United Kingdom
- Incorporated
- 2015-11-25
- Dissolved
- Not applicable
- Company number
- 09889431
Filing context
- Accounts category
- GROUP
- Accounts made up to
- 2024-12-31
- Next accounts due
- 2026-09-30
- Confirmation made up to
- 2026-04-10
- Registry snapshot
- 2026-08-01
- Live check
- 2026-08-25T03:36:11.945Z
Former registered names: 2D TECHNOLOGIES LIMITED
26110Manufacture of electronic components72190Other research and experimental development on natural sciences and engineering
Global legal-entity identifier
8945003MEQK1UBEM4R75
Exact company-number match to the GLEIF golden-copy data. An LEI is an identifier for a legal entity; it is not a credit, risk or investment-quality rating.
GLEIF record
- Legal name
- PARAGRAF LIMITED
- Entity status
- ACTIVE
- Jurisdiction
- GB
- Registration status
- ISSUED
- Last updated
- 2026-06-17T13:49:05+02:00
- Next renewal
- 2027-08-14T00:00:00+02:00
CompanyBeacon statutory projection
PARAGRAF LIMITED
UK Capital Intelligence owns the capital view on this page. CompanyBeacon owns the exact legal-entity, filing, control and public-record timeline for company number 09889431.
Latest retained status
active
- Checked
- 2026-08-25T03:36:11.945Z
- Recorded change
- No change timestamp retained
- Previous status
- active
- Fund associations
- 4 dated CompanyBeacon memberships
Boundary
Verify the legal record
Fund association does not prove a current holding. Status change is a review signal, not investment performance or wrongdoing. Ownership and control are not copied into this public UKCI package.
Open CompanyBeacon record ↗Traceability
Source trail
Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.